Detail Information of Transcriptional Regulations
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0500 Transporter Info | ||||
Gene Name | SLCO2A1 | ||||
Transporter Name | Organic anion transporting polypeptide 2A1 | ||||
Gene ID | |||||
UniProt ID | |||||
Transcriptional Regulation of This DT (TSR) | ||||||
---|---|---|---|---|---|---|
Class1.1: Basic leucine zipper factors |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
BACH1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLCO2A1 gene in breast cancer bone metastasis condition | [1] | ||||
TF Protein Name |
Transcription regulator protein BACH1 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Transcription regulator protein BACH1 (BACH1) has been reported to activate the transcription of SLCO2A1 gene in breast cancer bone metastasis condition, which leads to an increased expression of the drug transporter Organic anion transporting polypeptide 2A1. | |||||
CREB1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLCO2A1 gene | [2] | ||||
TF Protein Name |
Cyclic AMP-responsive element-binding protein 1 | Transcription Factor Info | ||||
Tissue |
Embryo; Liver | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Cyclic AMP-responsive element-binding protein 1 (CREB1) can directly bind to the SLCO2A1 gene, which in turn affects the expression or function of the drug transporter Organic anion transporting polypeptide 2A1. | |||||
Class1.2: Basic helix-loop-helix factors |
Click to Show/Hide the Full List of 5 TF(s) Regulating This DT |
|||||
AHR |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLCO2A1 gene in breast cancer condition | [3] | ||||
TF Protein Name |
Aryl hydrocarbon receptor | Transcription Factor Info | ||||
Affected Drug/Substrate |
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) | |||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Aryl hydrocarbon receptor (AHR) has been reported to activate the transcription of SLCO2A1 gene in breast cancer condition, which leads to an increased expression of the drug transporter Organic anion transporting polypeptide 2A1. | |||||
ARNT |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLCO2A1 gene in breast cancer condition | [3] | ||||
TF Protein Name |
Aryl hydrocarbon receptor nuclear translocator | Transcription Factor Info | ||||
Affected Drug/Substrate |
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) | |||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Aryl hydrocarbon receptor nuclear translocator (ARNT) has been reported to activate the transcription of SLCO2A1 gene in breast cancer condition, which leads to an increased expression of the drug transporter Organic anion transporting polypeptide 2A1. | |||||
TCF12 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLCO2A1 gene | [4] | ||||
TF Protein Name |
Transcription factor 12 | Transcription Factor Info | ||||
Tissue |
Blood; Brain; Uterus | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor 12 (TCF12) can directly bind to the SLCO2A1 gene, which in turn affects the expression or function of the drug transporter Organic anion transporting polypeptide 2A1. | |||||
TCF3 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLCO2A1 gene | [5] | ||||
TF Protein Name |
Transcription factor E2-alpha | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor E2-alpha (TCF3) can directly bind to the SLCO2A1 gene, which in turn affects the expression or function of the drug transporter Organic anion transporting polypeptide 2A1. | |||||
TCF4 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLCO2A1 gene in glioblastoma multiforme condition | [6] | ||||
TF Protein Name |
Transcription factor 4 | Transcription Factor Info | ||||
Affected Drug/Substrate |
Temozolomide | |||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Transcription factor 4 (TCF4) has been reported to bind to the transcription of SLCO2A1 gene in glioblastoma multiforme condition, which leads to an affected expression of the drug transporter Organic anion transporting polypeptide 2A1. | |||||
Class1.3: Basic helix-span-helix factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
TFAP2C |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLCO2A1 gene | [7] | ||||
TF Protein Name |
Transcription factor AP-2 gamma | Transcription Factor Info | ||||
Tissue |
Breast; Cervix; Skin | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor AP-2 gamma (TFAP2C) can directly bind to the SLCO2A1 gene, which in turn affects the expression or function of the drug transporter Organic anion transporting polypeptide 2A1. | |||||
Class2.1: Nuclear receptors with C4 zinc fingers |
Click to Show/Hide the Full List of 7 TF(s) Regulating This DT |
|||||
AR |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLCO2A1 gene in prostate cancer condition | [8] | ||||
TF Protein Name |
Androgen receptor | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Androgen receptor (AR) has been reported to bind to the transcription of SLCO2A1 gene in prostate cancer condition, which leads to an affected expression of the drug transporter Organic anion transporting polypeptide 2A1. | |||||
Transcriptional Phenomenon2 |
Direct binding to SLCO2A1 gene | [7] | ||||
TF Protein Name |
Androgen receptor | Transcription Factor Info | ||||
Tissue |
Breast; Cervix; Kidney; Prostate | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Androgen receptor (AR) can directly bind to the SLCO2A1 gene, which in turn affects the expression or function of the drug transporter Organic anion transporting polypeptide 2A1. | |||||
ESR1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLCO2A1 gene in breast cancer condition | [9] | ||||
TF Protein Name |
Estrogen receptor | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Estrogen receptor (ESR1) has been reported to bind to the SLCO2A1 gene in breast cancer condition, which leads to an affected expression of the drug transporter Organic anion transporting polypeptide 2A1. | |||||
ESR2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLCO2A1 gene in breast cancer condition | [9] | ||||
TF Protein Name |
Estrogen receptor beta | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Estrogen receptor beta (ESR2) has been reported to bind to the transcription of SLCO2A1 gene in breast cancer condition, which leads to an affected expression of the drug transporter Organic anion transporting polypeptide 2A1. | |||||
NR1I2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLCO2A1 gene in head and neck squamous cell carcinoma condition | [10] | ||||
TF Protein Name |
Nuclear receptor subfamily 1 group I member 2 | Transcription Factor Info | ||||
Studied Phenotype |
Head and neck squamous cell carcinoma [2D60.0] | |||||
Tissue |
Head and neck | |||||
Related DT Changes |
up regulating | |||||
Experimental Material |
Human head and neck squamous cell carcinoma isolates | |||||
Detailed Description |
Nuclear receptor subfamily 1 group I member 2 (NR1I2), influenced by the exogenous decitabine, has been reported to activate the transcription of SLCO2A1 gene in head and neck squamous cell carcinoma condition , which leads to an increased expression of the drug transporter Organic anion transporting polypeptide 2A1. | |||||
NR2F2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLCO2A1 gene | [2] | ||||
TF Protein Name |
COUP transcription factor 2 | Transcription Factor Info | ||||
Tissue |
Bone marrow; Breast; Liver | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
COUP transcription factor 2 (NR2F2) can directly bind to the SLCO2A1 gene, which in turn affects the expression or function of the drug transporter Organic anion transporting polypeptide 2A1. | |||||
PPARA |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Repression of SLCO2A1 gene in health condition | [11] | ||||
TF Protein Name |
Peroxisome proliferator-activated receptor alpha | Transcription Factor Info | ||||
Studied Phenotype |
Heallth [ICD11: N.A] | |||||
Tissue |
Liver | |||||
Related DT Changes |
Down regulating | |||||
Experimental Material |
C57BL/6 mice | |||||
Detailed Description |
Peroxisome proliferator-activated receptor alpha (PPARA) has been reported to repress the transcription of SLCO2A1 gene in health condition, which leads to a decreased expression of the drug transporter Organic anion transporting polypeptide 2A1. | |||||
PPARG |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLCO2A1 gene in health condition | [12] | ||||
TF Protein Name |
Peroxisome proliferator-activated receptor gamma | Transcription Factor Info | ||||
Studied Phenotype |
Heallth [ICD11: N.A] | |||||
Tissue |
Trophoderm | |||||
Related DT Changes |
up regulating | |||||
Experimental Material |
Pig conceptus trophoblast cells | |||||
Detailed Description |
Peroxisome proliferator-activated receptor gamma (PPARG), influenced by the exogenous rosiglitazone, has been reported to activate the transcription of SLCO2A1 gene in health condition , which leads to an increased expression of the drug transporter Organic anion transporting polypeptide 2A1. | |||||
Class2.2: Other C4 zinc finger-type factors |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
GATA3 |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLCO2A1 gene in breast cancer condition | [13] | ||||
TF Protein Name |
Trans-acting T-cell-specific transcription factor GATA-3 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Trans-acting T-cell-specific transcription factor GATA-3 (GATA3) has been reported to bind to the transcription of SLCO2A1 gene in breast cancer condition, which leads to an affected expression of the drug transporter Organic anion transporting polypeptide 2A1. | |||||
Transcriptional Phenomenon2 |
Direct binding to SLCO2A1 gene | [4] | ||||
TF Protein Name |
Trans-acting T-cell-specific transcription factor GATA-3 | Transcription Factor Info | ||||
Tissue |
Blood; Brain; Breast | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Trans-acting T-cell-specific transcription factor GATA-3 (GATA3) can directly bind to the SLCO2A1 gene, which in turn affects the expression or function of the drug transporter Organic anion transporting polypeptide 2A1. | |||||
GATA4 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLCO2A1 gene in gastric cancer condition | [14] | ||||
TF Protein Name |
Transcription factor GATA-4 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Transcription factor GATA-4 (GATA4) has been reported to activate the transcription of SLCO2A1 gene in gastric cancer condition, which leads to an increased expression of the drug transporter Organic anion transporting polypeptide 2A1. | |||||
Class2.3: C2H2 zinc finger factors |
Click to Show/Hide the Full List of 4 TF(s) Regulating This DT |
|||||
CTCF |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLCO2A1 gene | [2] | ||||
TF Protein Name |
Transcriptional repressor CTCF | Transcription Factor Info | ||||
Tissue |
Striated muscle | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcriptional repressor CTCF (CTCF) can directly bind to the SLCO2A1 gene, which in turn affects the expression or function of the drug transporter Organic anion transporting polypeptide 2A1. | |||||
MAZ |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLCO2A1 gene | [5] | ||||
TF Protein Name |
Myc-associated zinc finger protein | Transcription Factor Info | ||||
Tissue |
Blood; Lung | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Myc-associated zinc finger protein (MAZ) can directly bind to the SLCO2A1 gene, which in turn affects the expression or function of the drug transporter Organic anion transporting polypeptide 2A1. | |||||
ZNF217 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLCO2A1 gene in breast cancer condition | [15] | ||||
TF Protein Name |
Zinc finger protein 217 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Zinc finger protein 217 (ZNF217) has been reported to bind to the transcription of SLCO2A1 gene in breast cancer condition, which leads to an affected expression of the drug transporter Organic anion transporting polypeptide 2A1. | |||||
ZNF263 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLCO2A1 gene | [4] | ||||
TF Protein Name |
Zinc finger protein 263 | Transcription Factor Info | ||||
Tissue |
Kidney | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Zinc finger protein 263 (ZNF263) can directly bind to the SLCO2A1 gene, which in turn affects the expression or function of the drug transporter Organic anion transporting polypeptide 2A1. | |||||
Class3.1: Homeo domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
PBX1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLCO2A1 gene in ovarian cancer condition | [16] | ||||
TF Protein Name |
Pre-B-cell leukemia transcription factor 1 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Pre-B-cell leukemia transcription factor 1 (PBX1) has been reported to activate the transcription of SLCO2A1 gene in ovarian cancer condition, which leads to an increased expression of the drug transporter Organic anion transporting polypeptide 2A1. | |||||
Class3.3: Fork head / winged helix factors |
Click to Show/Hide the Full List of 3 TF(s) Regulating This DT |
|||||
E2F6 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLCO2A1 gene | [7] | ||||
TF Protein Name |
Transcription factor E2F6 | Transcription Factor Info | ||||
Tissue |
Embryo | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor E2F6 (E2F6) can directly bind to the SLCO2A1 gene, which in turn affects the expression or function of the drug transporter Organic anion transporting polypeptide 2A1. | |||||
FOXA2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLCO2A1 gene | [17] | ||||
TF Protein Name |
Hepatocyte nuclear factor 3-beta | Transcription Factor Info | ||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Hepatocyte nuclear factor 3-beta (FOXA2) has been reported to bind to the transcription of SLCO2A1 gene in . condition, which leads to a affected expression of the drug transporter Organic anion transporting polypeptide 2A1. | |||||
FOXP1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLCO2A1 gene | [5] | ||||
TF Protein Name |
Forkhead box protein P1 | Transcription Factor Info | ||||
Tissue |
Embryo; Prostate | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Forkhead box protein P1 (FOXP1) can directly bind to the SLCO2A1 gene, which in turn affects the expression or function of the drug transporter Organic anion transporting polypeptide 2A1. | |||||
Class3.5: Tryptophan cluster factors |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
FLI1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLCO2A1 gene | [4] | ||||
TF Protein Name |
Friend leukemia integration 1 transcription factor | Transcription Factor Info | ||||
Tissue |
Blood; Mesenchymal; Vein | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Friend leukemia integration 1 transcription factor (FLI1) can directly bind to the SLCO2A1 gene, which in turn affects the expression or function of the drug transporter Organic anion transporting polypeptide 2A1. | |||||
GABPA |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLCO2A1 gene | [7] | ||||
TF Protein Name |
GA-binding protein alpha chain | Transcription Factor Info | ||||
Tissue |
Embryo; Liver | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
GA-binding protein alpha chain (GABPA) can directly bind to the SLCO2A1 gene, which in turn affects the expression or function of the drug transporter Organic anion transporting polypeptide 2A1. | |||||
Class3.6: TEA domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
TEAD4 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLCO2A1 gene | [2] | ||||
TF Protein Name |
Transcriptional enhancer factor TEF-3 | Transcription Factor Info | ||||
Tissue |
Brain | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcriptional enhancer factor TEF-3 (TEAD4) can directly bind to the SLCO2A1 gene, which in turn affects the expression or function of the drug transporter Organic anion transporting polypeptide 2A1. | |||||
TF Superclass7: beta-Hairpin exposed by an alpha/beta-scaffold |
||||||
Class7.1: SMAD/NF-1 DNA-binding domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
SMAD4 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLCO2A1 gene in hESCs condition | [18] | ||||
TF Protein Name |
Mothers against decapentaplegic homolog 4 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Mothers against decapentaplegic homolog 4 (SMAD4) has been reported to activate the transcription of SLCO2A1 gene in human embryonic stem cells (hESCs) condition, which leads to an increased expression of the drug transporter Organic anion transporting polypeptide 2A1. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.